Home » Genzyme Fails to Win FDA Approval for Large-Scale Production of Pompe Drug
Genzyme Fails to Win FDA Approval for Large-Scale Production of Pompe Drug
Genzyme got some bad news from the FDA. The Cambridge, MA-based biotech company said that U.S. regulators determined its drug for Pompe disease made in large-scale vats isn’t ready to be approved for the market.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May